常见变体rs793391与COPD患者吸入皮质类固醇的反应有关
Charikleia Ntenti1,2, Eleni Papakonstantinou1, Leticia Grize1
1Clinic of Respiratory Medicine, University of Freiburg, Faculty of Medicine, University of Freiburg, 79098 Freiburg im Breisgau, Germany.
硫酶修饰因子-1 (SUMF1) 的特定基因变异可能预测慢性阻塞性肺病 (COPD) 的进展和对吸入性皮质类固醇 (ICS) 的反应. 在rs793391 SNP显示,在ICS治疗后肺功能得到改善.
科学领域:
- 遗传学和呼吸系统医学
- 药物基因组学 药物基因组学
- 慢性阻塞性肺病 (COPD) 研究研究
背景情况:
- 改变的硫酸酶修饰因子-1 (SUMF1) 表达及其遗传变异与COPD风险和进展有关.
- 之前的研究将特定的SUMF1SNP与肺功能联系起来,这表明它可能在COPD病变发生过程中发挥作用.
研究的目的:
- 研究SUMF1单核酸多态 (SNPs) 与COPD进展的关联.
- 为了确定SUMF1SNP是否影响COPD患者对吸入性皮质类固醇 (ICS) 治疗的反应,特别是布索尼德.
主要方法:
- 从SUMF1SNPs rs11915920和rs793391的HISTORIC研究中,对165名COPD患者进行基因定型.
- 一个为期12个月的随机对照试验,比较三重治疗 (LAMA/LABA/ICS) 与使用安慰剂吸入器的双重治疗 (LAMA/LABA).
主要成果:
- 与安慰剂相比,患有rs793391 TG基因型的COPD患者在ICS治疗时显示出显著的FEV1改善.
- 这种遗传关联得到了患者报告结果的改善,包括SGRQ,CAT得分和一般健康问卷得分.
结论:
- SUMF1 rs793391多态可能是COPD中ICS反应的预测生物标志物.
- 这些发现支持了基于遗传特征的COPD管理个性化医疗方法的潜力.
更多相关视频
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
相关概念视频
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Single Nucleotide Polymorphisms-SNPs
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
